Indian Pharmaceuticals Industry Poised To Achieve Steady Growth
Several industry reports and studies have highlighted how the pharmaceuticals industry in India is poised to touch 11% of growth over the next couple of years for achieving more than $60 billion with regard to overall size. These figures have been projected by CARE Ratings with increasing share in exports. Key industry growth drivers will include the capabilities of leveraging opportunities provided to Indian pharma entities owing to patent drug expiry factors worldwide and also regulatory risks coming down and adoption of several blueprints for de-risking raw material dependency on China. Other reasons could be robust industry fundamentals along with a growing trend towards PE (private equity) investments. Tapping into these available opportunities, CARE Ratings is anticipating stability of credit risk profiles for all its rated entities throughout the 2022 and 2023 financial years.
...